Intuitive Surgical
ISRG
Market cap $171B

468.44 USD

-7.72

1.62%

At close Aug 25, 4:00 PM EDT

After hours

469.03

+0.59

0.13%

1 day

-1.62%

5 days

-2.61%

1 month

-5.53%

3 months

-14.86%

6 months

-18.35%

Year to date

-10.61%

1 year

-2.24%

5 years

100.90%

10 years

752.64%

About: Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.

Employees: 15,638

Healthcare Medical Instruments & Supplies

0

Funds holding %

of 7,429 funds

0

Analysts bullish %

of 8 analysts

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

96% more first-time investments, than exits

New positions opened: 210 | Existing positions closed: 107

44% more repeat investments, than reductions

Existing positions increased: 999 | Existing positions reduced: 693

11% more capital invested

Capital invested by funds: $147B [Q1] → $163B (+$15.8B) [Q2]

3% more funds holding

Funds holding: 2,155 [Q1] → 2,209 (+54) [Q2]

0.79% more ownership

Funds ownership: 82.95% [Q1] → 83.74% (+0.79%) [Q2]

3% less call options, than puts

Call options by funds: $1.25B | Put options by funds: $1.29B

12% less funds holding in top 10

Funds holding in top 10: 75 [Q1] → 66 (-9) [Q2]

See Fund Rankings

Research analyst outlook

8 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$440

6%

downside

Avg. target

$569

22%

upside

High target

$615

31%

upside

8 analyst ratings

5 positive

63%

2 neutral

25%

1 negative

13%

RBC Capital Shagun Singh	31%upside $615	Outperform Reiterated	19 Aug 2025
UBS Danielle Antalffy	25%upside $585	Neutral Maintained	23 Jul 2025
Piper Sandler Adam Maeder	27%upside $595	Overweight Reiterated	23 Jul 2025
Truist Securities Richard Newitter	28%upside $600	Buy Maintained	23 Jul 2025
Wells Fargo Larry Biegelsen	28%upside $599	Overweight Maintained	23 Jul 2025

See Analyst Rankings

Financial journalist opinion

Based on 22 articles about ISRG published over the past 30 days

The Motley Fool

Should You Buy Intuitive Surgical Stock Today, or Wait for a Better Price?

One of famed investor Warren Buffett's principles is to buy shares of wonderful companies at fair prices to hold for the long term. Let's try to use it to decide whether Intuitive Surgical (ISRG 1.22%), a medical device specialist, is worth investing in today.

Should You Buy Intuitive Surgical Stock Today, or Wait for a Better Price?

The Motley Fool

2 Growth Stocks With Sky-High Potential to Hold for Decades

Investors searching for long-duration compounders don't need to overcomplicate things. One approach is to look for market-leading, platform-like business models with recurring economics and management teams investing for the next era of growth.

2 Growth Stocks With Sky-High Potential to Hold for Decades

Zacks Investment Research

Intuitive Surgical, Inc. (ISRG) Rises Yet Lags Behind Market: Some Facts Worth Knowing

Intuitive Surgical, Inc. (ISRG) closed at $476.16 in the latest trading session, marking a +1.34% move from the prior day.

Intuitive Surgical, Inc. (ISRG) Rises Yet Lags Behind Market: Some Facts Worth Knowing

3 Robotics Stocks at the Heart of the Robotics Revolution

Investors have been looking at robotics companies for several decades. But artificial intelligence (AI) is taking robotics beyond basic automation by bringing more precision, flexibility, and adaptability into the sector.

3 Robotics Stocks at the Heart of the Robotics Revolution

The Motley Fool

A Rise In Surgical Robotics Could Send These 2 Healthcare Stocks Soaring

The use of robotics in surgery is on the rise. The market was valued at $800 million in 2015, and has since risen to over $3 billion.

A Rise In Surgical Robotics Could Send These 2 Healthcare Stocks Soaring

Zacks Investment Research

Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.

Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know

Zacks Investment Research

ISRG's International Push for Ion: Strategic Bet or Overstretch?

Intuitive Surgical expands Ion into Australia and Korea after 52% procedure growth, testing Asia-Pacific adoption despite budget headwinds.

ISRG's International Push for Ion: Strategic Bet or Overstretch?

The Motley Fool

If You're in Your 30s, Consider Buying These 2 Healthcare Stocks

Investing styles tend to evolve as people age. Seniors who are already retired often look for steady, reliable, dividend-paying companies.

If You're in Your 30s, Consider Buying These 2 Healthcare Stocks

Zacks Investment Research

ISRG's Ion Platform Procedure Grows 52%: Can This Trend Continue?

Intuitive Surgical's Ion platform saw Q2 procedures jump 52% to 35,000, expanding globally as utilization rises despite softer system placements.

ISRG's Ion Platform Procedure Grows 52%: Can This Trend Continue?

Intuitive Surgical Has More Room To Grow

Intuitive Surgical's da Vinci system is driving strong global growth, with 17% YoY procedure growth and expanding adoption across hospitals and specialties. Recurring revenue streams from system sales, procedures, and services support robust financials, including 21% YoY revenue growth and 68% gross margins. The company's expanding installed base and accelerating procedure growth position it for continued earnings stability and long-term shareholder returns.

Intuitive Surgical Has More Room To Grow

See News Rankings

Charts implemented using Lightweight Charts™